학술논문

Psychosocial Care for People With Diabetic Neuropathy: Time for Action.
Document Type
Academic Journal
Author
Pouwer F; Department of Psychology, University of Southern Denmark, Odense, Denmark.; Steno Diabetes Center Odense, Odense, Denmark.; Department of Medical Psychology, Amsterdam UMC, Amsterdam, the Netherlands.; Mizokami-Stout K; Division of Metabolism, Endocrinology, and Diabetes, University of Michigan, Ann Arbor, MI.; Lieutenant Colonel Charles S. Kettles Veteran Affairs Medical Center, Ann Arbor, MI.; Reeves ND; Department of Life Sciences, Faculty of Science and Engineering, Manchester, U.K.; Pop-Busui R; Division of Metabolism, Endocrinology, and Diabetes, University of Michigan, Ann Arbor, MI.; Tesfaye S; Diabetes Research Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, U.K.; Boulton AJM; Diabetes, Endocrinology and Gastroenterology, University of Manchester, Manchester, U.K.; Department of Dermatology, University of Miami, Miami, FL.; Vileikyte L; Diabetes, Endocrinology and Gastroenterology, University of Manchester, Manchester, U.K.; Department of Dermatology, University of Miami, Miami, FL.
Source
Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print Cited Medium: Internet ISSN: 1935-5548 (Electronic) Linking ISSN: 01495992 NLM ISO Abbreviation: Diabetes Care Subsets: MEDLINE
Subject
Language
English
Abstract
Psychological factors and psychosocial care for individuals with diabetic neuropathy (DN), a common and burdensome complication of diabetes, are important but overlooked areas. In this article we focus on common clinical manifestations of DN, unremitting neuropathic pain, postural instability, and foot complications, and their psychosocial impact, including depression, anxiety, poor sleep quality, and specific problems such as fear of falling and fear of amputation. We also summarize the evidence regarding the negative impact of psychological factors such as depression on DN, self-care tasks, and future health outcomes. The clinical problem of underdetection and undertreatment of psychological problems is described, together with the value of using brief assessments of these in clinical care. We conclude by discussing trial evidence regarding the effectiveness of current pharmacological and nonpharmacological approaches and also future directions for developing and testing new psychological treatments for DN and its clinical manifestations.
(© 2023 by the American Diabetes Association.)